韻達股份(002120.SZ):成功發行5億美元境外債券
格隆匯 8 月 19日丨韻達股份(002120.SZ)公佈,公司發展戰略落地,滿足投資發展與資金期限的合理匹配需要,並進一步優化公司資本結構、降低融資成本,公司境外全資子公司YUNDA Holding Investment Limited(“YDHI”)擬在境外公開發行5億美元債券。
2020年8月19日,YDHI在境外完成此次5億美元債券的發行。此次債券在香港聯合交易所有限公司上市,上市日期為2020年8月19日。此次發行方式及規模:5億美元高級無抵押固息債券;債券簡稱:YD HOLD N2508;交易代碼:40347;債券利率:票面年息2.25%,每半年支付一次;債券期限:5年期。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.